Prokidney (PROK) Share-based Compensation (2021 - 2026)

Prokidney (PROK) has 6 years of Share-based Compensation data on file, last reported at $4.8 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 1390.37% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $14.4 million, a 64.43% decrease from a year earlier, with the FY2025 full-year figure at $26.9 million, down 33.76% from the prior year.
• Share-based Compensation for Q1 2026 stood at $4.8 million, up from $2.7 million in the prior quarter.
• Over the last five years, Share-based Compensation for PROK reached as high as $52.7 million in Q1 2022 and fell as low as -$64.0 million in Q4 2022.
• Historically, Share-based Compensation has averaged $9.1 million across 5 years, with a median of $7.7 million in 2024.
• On a YoY basis, Share-based Compensation climbed as much as 39900.0% in 2022 and fell as far as 320290.0% in 2022.
• Year by year, Share-based Compensation stood at -$64.0 million in 2022, then surged by 136.11% to $23.1 million in 2023, then gained by 15.67% to $26.8 million in 2024, then plunged by 89.82% to $2.7 million in 2025, then soared by 76.17% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $4.8 million in Q1 2026, $2.7 million in Q4 2025, and $30.8 million in Q3 2025.